Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats
T Furugohri, T Fukuda, N Tsuji, A Kita… - European journal of …, 2012 - Elsevier
There are concerns that some anticoagulants can paradoxically increase thrombogenesis
under certain circumstances. We have shown that low-dose administration of a direct …
under certain circumstances. We have shown that low-dose administration of a direct …
Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats.
T Furugohri, T Fukuda, N Tsuji, A Kita… - European Journal of …, 2012 - europepmc.org
There are concerns that some anticoagulants can paradoxically increase thrombogenesis
under certain circumstances. We have shown that low-dose administration of a direct …
under certain circumstances. We have shown that low-dose administration of a direct …
Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats
T Furugohri, T Fukuda, N Tsuji… - European journal …, 2012 - pubmed.ncbi.nlm.nih.gov
There are concerns that some anticoagulants can paradoxically increase thrombogenesis
under certain circumstances. We have shown that low-dose administration of a direct …
under certain circumstances. We have shown that low-dose administration of a direct …
Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats
T Furugohri, T Fukuda, N Tsuji, A Kita… - European Journal of …, 2012 - infona.pl
There are concerns that some anticoagulants can paradoxically increase thrombogenesis
under certain circumstances. We have shown that low-dose administration of a direct …
under certain circumstances. We have shown that low-dose administration of a direct …